Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pleural Effusion, Malignant 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Ifosfamide 17 Methotrexate 16 Doxorubicin 14 Filgrastim 13 Etoposide 12 Cisplatin 12 Cyclophosphamide 10 Gemcitabine 9 Leucovorin 8 Sirolimus 6 Carboplatin 6 Topotecan 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Temozolomide 4 Sorafenib 4 Radiotherapy 4 Peripheral Blood Stem Cell Transplantation 4 Docetaxel 4 trimetrexate glucuronate 3 temsirolimus 3 dinutuximab 3 cixutumumab 3 apatinib 3 Vincristine 3 Specimen Handling 3 Oxaliplatin 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Osteosarcoma × endostar protein × Clear all

NCT06562673 2025-12-29

IACE-OS

Shanghai 6th People's Hospital

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡